pH-Sensitive siRNA nanovector for targeted gene silencing and cytotoxic effect in cancer cells. - Wikidata - wikimedia - TriplyDB

pH-Sensitive siRNA nanovector for targeted gene silencing and cytotoxic effect in cancer cells.

pH-Sensitive siRNA nanovector for targeted gene silencing and cytotoxic effect in cancer cells.

http://www.wikidata.org/entity/Q34384339

about

Recent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and Imaging Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Nanoparticle-mediated systemic delivery of siRNA for treatment of cancers and viral infections.Recent advances in diagnosis and treatment of gliomas using chlorotoxin-based bioconjugates.Superparamagnetic iron oxide nanoparticle-based delivery systems for biotherapeutics Radiolabeling of poly(lactic-co-glycolic acid) (PLGA) nanoparticles with biotinylated F-18 prosthetic groups and imaging of their delivery to the brain with positron emission tomography.Pathogen-inspired drug delivery to the central nervous system.Cancer cell invasion: treatment and monitoring opportunities in nanomedicine.In vivo multimodal magnetic particle imaging (MPI) with tailored magneto/optical contrast agents Nanoparticle PEGylation for imaging and therapy.Responsive theranostic systems: integration of diagnostic imaging agents and responsive controlled release drug delivery carriers.Grapefruit-Derived Nanovectors Use an Activated Leukocyte Trafficking Pathway to Deliver Therapeutic Agents to Inflammatory Tumor Sites In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles Nanomaterials as Non-viral siRNA Delivery Agents for Cancer Therapy.N-Alkyl-PEI-functionalized iron oxide nanoclusters for efficient siRNA delivery Rigid nanoparticle-based delivery of anti-cancer siRNA: challenges and opportunities.Surface engineering of iron oxide nanoparticles for targeted cancer therapy.Chlorotoxin-conjugated nanoparticles as potential glioma-targeted drugs.In vivo imaging of the systemic delivery of small interfering RNA.Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy.In vivo gene delivery by nonviral vectors: overcoming hurdles?Multifunctional superparamagnetic iron oxide nanoparticles: design, synthesis and biomedical photonic applications.Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy.Functional nanostructures for effective delivery of small interfering RNA therapeutics.RNAi therapeutics for brain cancer: current advancements in RNAi delivery strategies.Chlorotoxin: Structure, activity, and potential uses in cancer therapy.Imaging-guided delivery of RNAi for anticancer treatment.Stimuli-Responsive Polymeric Nanocarriers for Efficient Gene Delivery.Advances in Peptide Functionalization on Mesoporous Silica Nanoparticles for Controlled Drug Release.Nanoparticle mediated silencing of DNA repair sensitizes pediatric brain tumor cells to γ-irradiation.Self-assembled magnetic theranostic nanoparticles for highly sensitive MRI of minicircle DNA delivery.Multistage pH-responsive liposomes for mitochondrial-targeted anticancer drug delivery.In vivo safety evaluation of polyarginine coated magnetic nanovectors.Polydopamine-Coated Porous Microspheres Conjugated with Immune Stimulators for Enhanced Cytokine Induction in Macrophages.A versatile approach towards multivalent saccharide displays on magnetic nanoparticles and phospholipid vesicles.Nanoparticle-mediated knockdown of DNA repair sensitizes cells to radiotherapy and extends survival in a genetic mouse model of glioblastoma.Engineering functional inorganic-organic hybrid systems: advances in siRNA therapeutics.Shape-, size- and structure-controlled synthesis and biocompatibility of iron oxide nanoparticles for magnetic theranostics.Superparamagnetic Nanoparticles and RNAi-Mediated Gene Silencing: Evolving Class of Cancer Diagnostics and Therapeutics Development of Magnetic Nanoparticles for Cancer Gene Therapy: A Comprehensive Review

P2860

Q26778234-23AD9178-3929-473B-9CA2-14BA02F8E3E5 Q26830028-E36372B3-F799-403B-BD59-C715FAF68DF7 Q33935474-7C3217CD-EEE6-4E5D-A69B-D3C256EBBB8F Q34066507-F2209BFC-466C-4018-B063-A895C3741E9C Q34205366-263E360D-5351-4666-B7CD-5E466572E0D3 Q34764435-B09D7EBC-3BD1-43DB-A3D0-A66FD2654F47 Q34929922-A04F684C-0BF0-4E4B-B953-4A4AD2CD2AD6 Q35093966-4FD94F23-8552-4A5E-ADC4-196F0CB60B43 Q35232459-9111B841-44BF-4A1B-86EC-45527EAB86C1 Q35553193-5B08BE3E-9EC1-400D-A9C4-13AAE8E34C08 Q35558487-5788A5CA-1362-4D8D-8050-B19955A735C6 Q35751910-BADF2084-449A-4A57-8CA2-E4ACDB80FD67 Q36289257-AA53AF63-6131-4800-9E7D-2B17C71B9C59 Q37020672-F91322A7-EE4F-4562-9677-C38415C7C789 Q37137333-0A77A902-CDF7-440A-8B7D-38BBE31F6428 Q37626377-579225B6-B162-419A-BAA4-67AC052EFAD9 Q37870178-F81C6088-B3AE-4769-947A-379678B896C5 Q37959770-071CB685-58F4-4690-9CFE-7788FA446032 Q37974175-98AF00E7-6F00-428B-A645-9654A36A3FF0 Q37978315-CD89F3BD-699A-4F31-937A-3F09DDEF77C4 Q38004708-E43BA068-D1BF-495E-A090-E7966173983B Q38123354-9F56554C-05D3-4830-BAEC-C4836CFCD11B Q38191832-9FB317DA-8585-4ECA-BF25-4C8AA7B9D479 Q38256970-7F1A3419-1121-49DC-8A8D-52C91995D932 Q38541950-56F1628F-5E4B-4967-8F94-111542768EED Q38595154-37A12023-A010-4C6E-8EEE-36AB72F2B866 Q38710046-EFC5E75C-F2C8-44B0-AEDE-BDB199B70EE6 Q38757883-E10991A8-3BDC-47B3-8541-9D3A17B9A43C Q38827516-B2443537-F92F-4662-A513-0068D01ADC6A Q38909841-37DA9BD1-A117-410C-801B-021655E94415 Q39229853-DA8F80E3-20BF-45D3-8222-4E51B7AE2000 Q39334978-82F86C2A-5BE3-4FFA-9CC0-06A211FF624E Q42117571-9AFC220E-5044-40B4-904E-CB67EE114700 Q42808314-3451DF20-8172-488F-ACE9-44A5E1FB44DB Q42823044-B935621F-4B86-4713-90C5-2EAB3446A9FD Q48018806-60D9A900-0F02-4115-90AF-D460BEABC734 Q50123721-2A94B5E4-E3EB-46B9-B8CA-55863279F8FE Q55450179-664CB39C-9FF4-4627-AB14-B31EA692ED4E Q58909203-2E5EAD72-20F7-439E-A0A9-8E3B22A8BD57 Q58998029-222EF480-2C10-4DDE-9F29-7752E4BEA035

P2860

pH-Sensitive siRNA nanovector for targeted gene silencing and cytotoxic effect in cancer cells.

http://www.wikidata.org/entity/Q34384339

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

pH-Sensitive siRNA nanovector ...... otoxic effect in cancer cells.

@ast

pH-Sensitive siRNA nanovector ...... otoxic effect in cancer cells.

@en

pH-Sensitive siRNA nanovector ...... otoxic effect in cancer cells.

@nl

type

label

pH-Sensitive siRNA nanovector ...... otoxic effect in cancer cells.

@ast

pH-Sensitive siRNA nanovector ...... otoxic effect in cancer cells.

@en

pH-Sensitive siRNA nanovector ...... otoxic effect in cancer cells.

@nl

prefLabel

pH-Sensitive siRNA nanovector ...... otoxic effect in cancer cells.

@ast

pH-Sensitive siRNA nanovector ...... otoxic effect in cancer cells.

@en

pH-Sensitive siRNA nanovector ...... otoxic effect in cancer cells.

@nl

P1433

Q34384339-A706BAA6-8C30-4A57-83EB-E912E4EC66A0

P1476

Q34384339-0946BE63-8A57-45FD-BCA6-664D817223CF

P2093

Q34384339-2614BD95-607D-4525-807A-2D334177F421

Q34384339-4618BF16-7F18-4E04-B07E-4EA869D1B549

Q34384339-8332A0E3-4CCE-4EC4-8C20-5C11F3FBFC5E

Q34384339-9BE48DAE-472E-4F59-9396-D3CEB458BBE4

Q34384339-AD093CA0-AEAC-4B3C-A613-6317BD8D3EA4

Q34384339-BEBFF70D-85F3-4FF8-9087-FDAD07508437

Q34384339-EDBF8503-F83D-40DD-8E0B-9561D1F0471A

P2860

Q34384339-000E73E0-B159-4ECB-8EBA-E7D5BA3CCAB9

Q34384339-077A93D5-93C5-461F-820A-62BE396226BE

Q34384339-0B0EF91D-4E3C-4563-BE61-E2AC65E6E0F1

Q34384339-12C9E46D-4327-4BF2-B2CA-8BB5CBB751A1

Q34384339-1A503498-71E3-4D71-AC4C-9219598668F6

Q34384339-299DA65F-C4E2-4136-8B00-5A11A0EEF5D1

Q34384339-2A8C961A-2B83-4033-A581-114FD0E29A4E

Q34384339-2C362134-A23B-48E5-9050-C55A527C20A4

Q34384339-33ACFD2C-D22B-4F57-8B81-4965801AAFDC

Q34384339-3531E2EC-9BA0-4A47-9AA4-FFA062F20E2F

P304

Q34384339-7ADD19AE-5CC3-4DDC-BB33-B78C153E4E49

P31

Q34384339-E359A71C-2A64-443D-9A77-DC38DCC73B22

P356

Q34384339-02B914CF-9BF7-40E5-A1D3-F54D73E05D7B

P407

Q34384339-D76ED964-89AD-410E-8600-28B96A1CD0A2

P433

Q34384339-4007E142-A86E-42E2-A39C-4633D6E2474B

P478

Q34384339-18898141-DA98-4C35-A354-82A14368BA95

P577

Q34384339-A4BFB79A-67F2-4C93-9D4B-EE9235AD379D

P5875

Q34384339-34ED232D-A150-4474-B5E9-7202DD877477

P698

Q34384339-4E1ADADD-4F91-4637-9CF3-99251EC5AFD4

P921

Q34384339-0DFE8C50-974E-4F3B-9DBD-8F5A793E3038

Q34384339-6F22815A-B701-4894-9D1A-05B36976EB20

P932

Q34384339-A7A57960-DE57-4B6F-9EB3-B68A6C63EDBE

P356

P1433

Molecular Pharmaceutics

P1476

pH-Sensitive siRNA nanovector ...... otoxic effect in cancer cells.

@en

P2093

Chen Fang

http://www.w3.org/2001/XMLSchema#string

Forrest M Kievit

http://www.w3.org/2001/XMLSchema#string

Freddy Y Wang

http://www.w3.org/2001/XMLSchema#string

Hyejung Mok

http://www.w3.org/2001/XMLSchema#string

James O Park

http://www.w3.org/2001/XMLSchema#string

Miqin Zhang

http://www.w3.org/2001/XMLSchema#string

Omid Veiseh

http://www.w3.org/2001/XMLSchema#string

P2860

Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2

Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci

Magnetic nanoparticles for theragnostics

In vitro toxicity of nanoparticles in BRL 3A rat liver cells

Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications

Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery.

Folate immobilized and PEGylated adenovirus for retargeting to tumor cells.

Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery.

Functionalized nanoparticles with long-term stability in biological media.

In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis.

P304

1930-1939

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/MP100221H

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45718809

http://www.w3.org/2001/XMLSchema#string

P698

20722417

http://www.w3.org/2001/XMLSchema#string

P921

P932

2997854

http://www.w3.org/2001/XMLSchema#string